Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. May 28, 2022; 28(20): 2214-2226
Published online May 28, 2022. doi: 10.3748/wjg.v28.i20.2214
Figure 3
Figure 3 Comparison of four noninvasive methods before and after sustained virological response between patients with fibrosis regression or not. A: Value of contrast enhancement index; B: Value of liver stiffness measurement; C: Value of aspartate aminotransferase-to-platelet ratio index; D: Value or Fibrosis-4 in patients with (Red column) and without (Black column) fibrosis regression at baseline and after achieving sustained virological response (SVR). Red column: Patients had fibrosis regression after achieving SVR (n = 7). Black column: Patients didn’t have fibrosis regression after achieving SVR (n = 14). aP < 0.05; bP < 0.001. CEI: Contrast enhancement index; SVR: Sustained virological response; LSM: Liver stiffness measurement; APRI: Aspartate aminotransferase-to-platelet ratio index; FIB-4: Fibrosis-4.